Hodgkin's lymphoma: Immunohistochemical features and its association with EBV LMP-1. Experience from a South Indian hospital

Pathology

Volumn 35, Issue 3, 2003, Pages 207-211

  Karnik, Swapnil ^a   Srinivasan, Bhuvana ^a   Nair, Sheila ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

EBV LMP 1; Hodgkin's lymphoma; Immunohistochemistry

Indexed keywords

CD15 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; LATENT MEMBRANE PROTEIN 1; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DIAGNOSTIC VALUE; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HOSPITAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INDIA; LYMPH NODE BIOPSY; LYMPHOCYTE DEPLETION; MALE; REED STERNBERG CELL;

EID: 0038163886     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/0031302031000123164     Document Type: Article

References (41)

1. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res 1966; 26: 1063-91.
2. Lukes RJ, Craver LF, Hall TC, Rappaport H, Ruben P. Report of the nomenclature committee. Cancer Res 1966; 26: 1311.
3. Zukerberg LR, Collins BA, Ferry JA, Harris NL. Co-expression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease. Am J Pathol 1991; 139: 475-83.
4. Warnke RA, Weiss LM, Chan KC, Cleary ML, Dorfman RF. Tumors of the Lymph Nodes and Spleen. Atlas of Tumor Pathology. 3rd series, Fascicle 14. Washington, DC: AFIP, 1994; Chapter 14, Classical Hodgkin's disease.
5. Chan WC. Cellular origin of nodular lymphocyte predominance Hodgkin's disease: immunophenotypic and molecular studies. Semin Hematol 1999; 36: 242-52.
6. Weinreb M, Day PR, Murray PG, et al. Epstein-Barr virus (EBV) and Hodgkin's disease in children: incidence of EBV Latent Membrane Protein in malignant cells. J Pathol 1992; 168: 365-9.
7. Pinkus GS, Lones M, Shintaku IP, Said JW. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease. Mod Pathol 1994; 7: 454-61.
8. Axdorph U, Porwit MA, Sjoberg J, et al. Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function. Br J Cancer 1999; 81: 1182-7.
9. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000; 36: 69-87.
10. Nair S, Krishnaswami H. Non-Hodgkin's lymphomas in a south Indian Hospital. Our experience with International Working Formulation. Ind J Pathol Microbiol 1990; 33: 17-22.
11. Braunwald E, Fauci A, Kasper D, Hauser S, Longo D, Jameson JL. Harrison's Principles Of Internal Medicine. 15th Edition. New York: McGraw Hill Medical Publishing Division, 2001; Chapter 112, Malignancies of lymphoid cells.
12. Nanda KA. Descriptive epidemiology of lymphoid and haemopoietic malignancies in Bangalore, India. Int J Cancer 1995; 63: 37-42.
13. Chittal SM, Caveriviere P, Schwarting R, et al. Monoclonal antibodies in the diagnosis of Hodgkin's disease. Am J Surg Pathol 1988; 12: 9-21.
14. Dorfman RF, Gatter KC, Pulford KF, Mason DY. An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease. Am J Pathol 1986; 123: 503-19.
15. Medeiros LJ, Weiss LM, Warnke RA, Dorfman RF. Utility of combining anti-granulocyte with antileucocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma. Cancer 1988; 62: 2475-81.
16. Osorno AZ, Roman LN, Kingma DW, Garcia AM, Jaffe E. Hodgkin's disease in Mexico. Cancer 1995; 75: 1130-6.
17. Hsu SM, Yang K, Jaffe ES. Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease. Am J Pathol 1985; 118: 209-17.
18. Orazi A, Jiang B, Lee CH, et al. Correlation between presence of clonal rearrangements of immunoglobin heavy chain genes and B-cell antigen expression in Hodgkin's disease. Am J Clin Pathol 1995; 104: 413-8.
19. Strickler JG, Weiss LM, Copenhaver CM, et al. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma with emphasis on T-cell lymphomas. Hum Pathol 1987; 18: 808-14.
20. Pinkus GS, Said JW. Hodgkin's disease, lymphocyte predominance type, nodular - further evidence for a B-cell derivation. L&H variants of Reed-Sternberg cells express L26, a pan B-cell marker. Am J Pathol 1998; 133: 211-7.
21. Stein H, Hansmann ML, Lennert K, et al. Reed-Sternberg and Hodgkin's cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. Am J Clin Pathol 1986; 86: 292-7.
22. Liu SM, Chow KC, Chiu CF, Tzeng CH. Expression of Epstein-Barr virus in patients with Hodgkin's disease in Taiwan. Cancer 1998; 83: 367-71.
23. Jarrett RF, Mackenzie J. Epstein-Barr virus and other antidate viruses in the pathogenesis of Hodgkin's disease. Semin Hematol 1999; 36: 260-9.
24. Radha K, Shanthi P, Madhavan M, Senthamarai A. Study of association of Epstein-Barr virus with Hodgkin's disease. Ind J Pathol Microbiol 1997; 40: 351-4.
25. Naresh KN, Johnson J, Srinivas V, et al. Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Ann Oncol 2000; 11: 91-6.
26. Quintanilla ML, Gamboa DA, Gamez LI, Angeles AA, Mohar A. Association of EBV LMP1 and Hodgkin's disease in Mexico. Mod Pathol 1995; 8: 675-9.
27. Bamanikar S, Thunold S, Devi KR, Bamanikar A. The pattern of malignant lymphoma in Oman. J Trop Med Hyg 1995; 98: 351-4.
28. Huh J, Park C, Kim CE, Popema S, Kim C. A pathologic study of Hodgkin's disease in Korea and its association with EBV infection. Cancer 1996; 17: 949-55.
29. Revesz T, Mpofu C, Oyejide C. Ethnic differences in lymphoid malignancies of children in the United Arab Emirates. A clue to etiology. Leukemia 1995; 9: 189-93.
30. Preciado MV, Diez B, Grinstein S. Epstein-Barr virus in Argentine Pediatric Hodgkin's disease. Leuk Lymphoma 1997; 24: 283-90.
31. Tomita Y, Ohsawa M, Ohnishi A, Nakanishi H, Aozasa K. Epstein-Barr virus in Hodgkin's disease patients in Japan. Cancer 1996; 77: 186-92.
32. Chan JK, Yip TT, Tsang WY, et al. Detection of EBV in Hodgkin's disease occurring in an oriental population. Hum Pathol 1995; 26: 314-8.
33. Paulino AF, Paulino CE, Weiss LM, Medeiros LJ. Hodgkin's disease in the Philippines. Mod Pathol 1996; 9: 115-9.
34. Peh SC, Looi LM, Pallosen G. Epstein-Barr virus and Hodgkin's disease in a multiethnic population in Malaysia. Histopathology 1997; 30: 227-33.
35. Sukpanichnant S, Sonakul D, Piankijagum A, Mahosandana C, Suvatte V. Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj Hospital. Cancer 1998; 83: 1197-204.
36. Cool CD, Bitter MA. The malignant lymphomas of Kenya: morphology, immunophenotype and frequency of Epstein-Barr virus in 73 cases. Hum Pathol 1997; 28: 1026-32.
37. Faria SL, Vassallo J, Cosset JM. Childhood Hodgkin's disease in Campinas, Brazil. Med Pediatr Oncol 1996; 26: 90-4.
38. Belkaid MI, Briere J, Djebbara Z, et al. Comparison of EBV markers in Reed-Sternberg cells in adult Hodgkin's disease tissues from an industrialized and a developing country. Leuk Lymphoma 1995; 17: 163-8.
39. Kusuda M, Toriyama K, Kamidigo N, Itakuro HA. Comparison of epidemiologic histologic and virologic studies on Hodgkin's disease in Western Kenya and Nagasaki, Japan. Am J Trop Med Hyg 1998; 59: 801-7.
40. Ambinder RF, Browning PJ, Lorenzana I, et al. Epstein-Barr virus and Hodgkin's disease in Honduras and the US. Blood 1993; 81: 462-7.
41. Monterros V, Zhou Y, Koo S, et al. Hodgkin's disease in Costa Rica. A report of 40 cases analysed for Epstein-Barr virus. Am J Clin Pathol 1998; 109: 618-24.